A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics
- Indications Breast cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Sponsors GlaxoSmithKline
- 09 Mar 2015 Biomarkers information updated
- 21 Jun 2013 Planned end date changed from 1 Dec 2019 to 1 Jul 2023 as reported by ClinicalTrials.gov.
- 07 Jun 2013 Actual initiation date changed from Nov 2011 to Dec 2011 as reported by ClinicalTrials.gov.